Med-tech funding outlook improves as dealmaking accelerates
· shani alexander
AI Briefing
- • Med-tech M&A activity is increasing, indicating a positive trend for investment.
- • Medtronic's acquisition and Neurent Medical's large fundraise signal improved sentiment.
- • Claret Capital Partners sees encouraging signs in the med-tech investment environment.
Context
Med-tech funding is showing signs of improvement due to increased M&A activity and large financing rounds. Joey Mason, life sciences venture partner at Claret Capital Partners, views this trend as a positive development. Recent deals, such as Medtronic plc's acquisition of SPR Therapeutics Inc, demonstrate the uptick in activity.
The increase in dealmaking is a promising sign for the med-tech investment environment. Large fundraises, like the one by Neurent Medical Ltd, also contribute to the improving sentiment, according to Mason.
Advertisement